K. Sides

A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity.

Xin Chen, Qingping Wang, Jiesheng Kang, 2012, Bioorganic & medicinal chemistry letters.

Structure-based design, synthesis, and profiling of a β-tryptase inhibitor with a spiro-piperidineamide scaffold, benzylamine P1 group, and a substituted indole P4 group

Roy J. Vaz, Xin Chen, Qingping Wang, 2011 .

Syncytiotrophoblast basal plasma membrane isolation.

P. Ayuk, K. Sides, A. Grey, 1998, Placenta.

Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human β-tryptase

Roy J. Vaz, Xin Chen, F. Liu, 2004 .

Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.

M. Mathieu, C. Hopkins, S. Jackson, 2004, Bioorganic & medicinal chemistry letters.

A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO).

Roy J. Vaz, Xin Chen, Qingping Wang, 2010, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.

M. Mathieu, C. Hopkins, S. Kaye, 2005, Bioorganic & medicinal chemistry letters.

Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?

I. Morize, Xin Chen, G. Liang, 2012, Bioorganic & medicinal chemistry letters.

Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase

S. Rebello, D. Engers, A. Dupuy, 2005 .

Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenografts.

D. Goldenberg, R. Sharkey, R. Blumenthal, 1997, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent.

I. Morize, M. Mathieu, Xin Chen, 2012, Bioorganic & medicinal chemistry letters.

Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase.

S. Rebello, D. Engers, A. Dupuy, 2005, Bioorganic & medicinal chemistry.